JP5040060B2 - Methionine combination oral solution - Google Patents

Methionine combination oral solution Download PDF

Info

Publication number
JP5040060B2
JP5040060B2 JP2004300219A JP2004300219A JP5040060B2 JP 5040060 B2 JP5040060 B2 JP 5040060B2 JP 2004300219 A JP2004300219 A JP 2004300219A JP 2004300219 A JP2004300219 A JP 2004300219A JP 5040060 B2 JP5040060 B2 JP 5040060B2
Authority
JP
Japan
Prior art keywords
extract
methionine
present
odor
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004300219A
Other languages
Japanese (ja)
Other versions
JP2006111566A (en
Inventor
博子 上保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP2004300219A priority Critical patent/JP5040060B2/en
Publication of JP2006111566A publication Critical patent/JP2006111566A/en
Application granted granted Critical
Publication of JP5040060B2 publication Critical patent/JP5040060B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicinal Preparation (AREA)

Description

本発明は、内服液剤において発生する不快臭が軽減された飲料組成物に関するものである。   The present invention relates to a beverage composition in which an unpleasant odor generated in an internal solution is reduced.

メチオニンおよびビタミンB2類は様々な薬効が知られており、医薬品、医薬部外品、食品などに広く配合されている。しかし、メチオニンとビタミンB2類を液剤中に同時に配合すると、経時的にメチオニンに固有の不快臭を発生させることが知られている。そのため風味において満足できるものは得られなかった。   Methionine and vitamin B2 are known to have various medicinal effects and are widely incorporated in pharmaceuticals, quasi drugs, foods and the like. However, it is known that when methionine and vitamin B2 are mixed simultaneously in a liquid, an unpleasant odor inherent to methionine is generated over time. Therefore, a satisfactory flavor was not obtained.

従来、メチオニン由来の不快な風味を改善する技術としては、不快な風味を有するチアミン誘導体を配合することによりお互いの不快風味で相殺して、風味を改善する技術(特許文献1)が開示されている。   Conventionally, as a technique for improving an unpleasant flavor derived from methionine, a technique (Patent Document 1) for improving the flavor by offsetting each other's unpleasant flavor by blending thiamine derivatives having an unpleasant flavor has been disclosed. Yes.

しかし、メチオニンとビタミンB2類を液剤中に同時配合した際に発生する不快臭を簡便に改善する技術は知られていない。   However, there is no known technique for simply improving the unpleasant odor that is generated when methionine and vitamin B2 are simultaneously mixed in a liquid preparation.

特開平10−287551JP-A-10-287551

本発明は、メチオニンとビタミンB2類を同時配合した際に経時的に発生する不快臭を抑制した内服液剤を提供することにある。   An object of the present invention is to provide an internal liquid that suppresses an unpleasant odor that is generated over time when methionine and vitamin B2 are blended simultaneously.

本発明者は、上記目的を達するため鋭意研究を進めた結果、内服液剤にメチオニンとビタミンB2類を同時配合しても、特定の活性酸素発生抑制成分およびポリグリセリン脂肪酸エステルから選ばれる少なくとも1種を配合することにより不快臭の発生を抑制できることを見出し本発明を完成した。   As a result of diligent research to achieve the above object, the present inventor has obtained at least one selected from a specific active oxygen generation inhibiting component and a polyglycerin fatty acid ester even when methionine and vitamin B2 are simultaneously blended in an internal liquid. The present invention was completed by finding out that the generation of unpleasant odor can be suppressed by blending of.

すなわち本発明はメチオニン、ビタミンB2類ならびに、活性酸素発生抑制成分およびポリグリセリン脂肪酸エステルから選ばれる1種または2種を含む内服液剤である。   That is, the present invention is an oral liquid preparation containing methionine, vitamin B2 and one or two active oxygen generation inhibiting components and polyglycerin fatty acid ester.

本発明で用いるメチオニンは通常内服液剤に配合することができるものを配合でき、具体的にはL-メチオニン、DL-メチオニンなどをあげることができる。本発明において配合するメチオニンの配合量は、内服液剤全体の0.001〜0.4W/V%が好ましい。配合量が0.001W/V%未満であると発生する不快臭はそれほど強くなく、配合量が0.4W/V%を超えると本発明によっても不快臭の発生抑制効果が不十分な場合があるからである。   As the methionine used in the present invention, those which can be usually blended in an internal liquid preparation can be blended, and specific examples include L-methionine, DL-methionine and the like. The blending amount of methionine blended in the present invention is preferably 0.001 to 0.4 W / V% of the whole internal use liquid. The unpleasant odor that occurs when the blending amount is less than 0.001 W / V% is not so strong, and when the blending amount exceeds 0.4 W / V%, the present invention may not be effective in suppressing the generation of unpleasant odor. Because there is.

本発明で用いるビタミンB2類は通常内服液剤に配合することができるものを配合でき、具体的にはリボフラビン、リン酸リボフラビン、酪酸リボフラビン、それらの塩などをあげることができる。本発明において配合することができるビタミンB2類の配合量は内服液剤全体の0.02W/V%〜0.4W/V%である。配合量が少ないと発生する不快臭はそれほど強くなく、配合量が多いと苦味が生じるからである。   As the vitamin B2 used in the present invention, those that can be usually blended in internal liquids can be blended, and specific examples include riboflavin, riboflavin phosphate, riboflavin butyrate, and salts thereof. The compounding quantity of vitamin B2 which can be mix | blended in this invention is 0.02 W / V%-0.4 W / V% of the whole internal use liquid agent. This is because the unpleasant odor generated when the blending amount is small is not so strong, and when the blending amount is large, bitterness is generated.

本発明で活性酸素発生抑制成分とは、液剤中で活性酸素の発生を抑制する効果を有する成分であり、活性酸素発生抑制効果を有する着色料、活性酸素発生抑制効果を有する生薬成分、多価フェノール、亜硫酸ナトリウムなどをあげることができる。   In the present invention, the active oxygen generation suppressing component is a component having an effect of suppressing the generation of active oxygen in the liquid agent, a colorant having an active oxygen generation suppressing effect, a herbal medicine component having an active oxygen generation suppressing effect, a polyvalent Examples thereof include phenol and sodium sulfite.

ここで、本発明で用いる活性酸素発生抑制効果を有する着色料は、具体的には黄色5号、黄色4号、赤色2号、赤色102号、青色2号、βカロテンなどがあげられ、特に黄色5号が好ましい。着色料の配合量は液剤全体の0.01〜0.1W/V%が好ましい。   Here, specific examples of the colorant having an effect of suppressing the generation of active oxygen used in the present invention include Yellow No. 5, Yellow No. 4, Red No. 2, Red No. 102, Blue No. 2, β-carotene, and the like. Yellow No. 5 is preferred. The blending amount of the colorant is preferably 0.01 to 0.1 W / V% of the whole liquid agent.

本発明で活性酸素発生抑制効果を有する生薬成分の好ましいものとしてはエゾウコギ、オウセイ、クコシ、シャクヤク、チンピ、トシシ、ローヤルゼリー、ハゲキテン、センキュウおよびビャクジュツをあげることができ、特に好ましいものとしてカンゾウをあげることができる。生薬の配合量は原生薬換算で液剤全体の0.005〜2W/V%が好ましい。   Preferred herbal medicine components having an effect of suppressing the generation of active oxygen in the present invention include sorghum, seisei, kokushi, peonies, chimpi, toshishi, royal jelly, bald getten, nematode and peanut. Particularly preferred is licorice. Can do. The blending amount of the crude drug is preferably 0.005 to 2 W / V% of the total liquid in terms of the crude drug.

配合する生薬は、エキスの形態での配合が好ましい。エキスの製造は通常の方法、例えば、抽出溶媒を用いて、適当な温度(低温又は加熱)にて、生薬原料から抽出する方法などにより行う。抽出溶媒は生薬に応じて適当に選択できるが、好ましくは、水、親水性溶媒(特にエタノール)およびこれらの混合溶媒が用いられる。本発明のエキスとは、液状抽出物をそのまま使用できるほか、水などで希釈したもの、液状抽出物の濃縮物、液状抽出物の乾固物としても使用できる。すなわち、本発明のエキスには、乾燥エキス、軟エキス、流エキス、チンキなどいずれのものも包含される。   The herbal medicine to be blended is preferably blended in the form of an extract. The extract is produced by an ordinary method, for example, a method of extracting from a crude drug raw material at an appropriate temperature (low temperature or heating) using an extraction solvent. The extraction solvent can be appropriately selected depending on the crude drug, but preferably water, a hydrophilic solvent (especially ethanol) and a mixed solvent thereof are used. As the extract of the present invention, a liquid extract can be used as it is, or it can be used as a diluted product of water or the like, a concentrate of a liquid extract, or a dried product of a liquid extract. That is, the extract of the present invention includes any of dry extract, soft extract, flow extract, tincture and the like.

本発明に用いる多価フェノール化合物は、同一分子内に2個以上のフェノール性水酸基を持つ化合物を意味し、具体的には没食子酸、その酸の誘導体、例えば没食子酸メチル、エチル、プロピル、ブチルエステル及び没食子酸のナトリウム、カリウムなどのアルカリ金属塩,クロロゲン酸、エラグ酸、タンニン酸、タンニン(例えばプロアントシアニジン、ガロタンニン、エラグタンニン)、フラボノイド類(例えばフラボン、フラボノール、フラバノン、フラバノノール、イソフラボン、アントシアニン、フラバノール(カテキン、エピカテキン、ガロカテキン、エピガロカテキン、エピカテキンガレート、エピガロカテキンガレート等))、カルコン、オーロンが挙げられる。特に飲料組成物全体の風味の面から、没食子酸及びその誘導体が好ましい。多価フェノール化合物は一種又は二種以上を任意に組み合わせて用いることができ、好ましい配合量は0.1〜0.001W/V%である。   The polyhydric phenol compound used in the present invention means a compound having two or more phenolic hydroxyl groups in the same molecule. Specifically, gallic acid, its derivatives, such as methyl gallate, ethyl, propyl, butyl Esters and alkali metal salts such as sodium and potassium of gallic acid, chlorogenic acid, ellagic acid, tannic acid, tannin (eg proanthocyanidins, gallotannins, ellagitannins), flavonoids (eg flavones, flavonols, flavanones, flavonols, isoflavones, anthocyanins) Flavanols (catechin, epicatechin, gallocatechin, epigallocatechin, epicatechin gallate, epigallocatechin gallate, etc.), chalcone and aurone. In particular, gallic acid and its derivatives are preferable from the aspect of the flavor of the whole beverage composition. The polyphenol compound can be used singly or in combination of two or more, and the preferred blending amount is 0.1 to 0.001 W / V%.

本発明に用いる多価フェノール化合物は、合成品だけでなく、植物抽出物、果汁等およびそれらの由来物として添加してもよい。具体的には緑茶ポリフェノール、赤ワインポリフェノール、リンゴポリフェノール、ブドウ種子ポリフェノール、ブドウ葉ポリフェノール、ウーロン茶ポリフェノール、シソポリフェノール、ソバポリフェノール、カカオポリフェノール、コーヒーポリフェノール、甜茶ポリフェノール、シソ抽出物、カカオ抽出物、ソバ抽出物、柑橘果皮抽出物、ブルーベリー抽出物、緑茶抽出物、コーヒー抽出物、リンゴ抽出物、月見草抽出物、ウーロン茶抽出物、ブドウ種子抽出物、ブドウ葉抽出物、ユーカリ抽出物、グァバ抽出物、甜茶抽出物、ライチ種子抽出物、クランベリー抽出物、大豆イソフラボンなどが挙げられる。特に飲料組成物全体の風味の面から、緑茶ポリフェノール、リンゴポリフェノール、緑茶抽出物、リンゴ抽出物が好ましい。   The polyhydric phenol compound used in the present invention may be added not only as a synthetic product but also as a plant extract, fruit juice, and the like and their derivatives. Specifically, green tea polyphenol, red wine polyphenol, apple polyphenol, grape seed polyphenol, grape leaf polyphenol, oolong tea polyphenol, perilla polyphenol, buckwheat polyphenol, cacao polyphenol, coffee polyphenol, persimmon tea polyphenol, perilla extract, cacao extract, buckwheat extract , Citrus peel extract, blueberry extract, green tea extract, coffee extract, apple extract, evening primrose extract, oolong tea extract, grape seed extract, grape leaf extract, eucalyptus extract, guava extract, strawberry tea extract Products, lychee seed extract, cranberry extract, soybean isoflavone and the like. In particular, green tea polyphenol, apple polyphenol, green tea extract, and apple extract are preferable from the aspect of the flavor of the entire beverage composition.

本発明では、好ましいポリグリセリン脂肪酸エステルとしてデカグリセリンモノステアリン酸エステルおよびデカグリセリンモノミリスチン酸エステルをあげることができる。   In the present invention, preferred polyglycerin fatty acid esters include decaglycerin monostearate and decaglycerin monomyristate.

本発明の内服液剤は、不快臭の改善効果の点からpH2〜6の範囲が好ましく、pH2.5〜5がさらに好ましい。pH調整は、可食性の酸をpH調整剤として用いることができる。pH調整剤としては、クエン酸、リンゴ酸、酒石酸、フマル酸、乳酸、コハク酸、アスコルビン酸、酢酸などの有機酸およびそれらの塩類、塩酸、リン酸などの無機酸およびそれらの塩類などがあげられる。これらのpH調整剤は一種又は二種以上使用できる。   The internal liquid preparation of the present invention is preferably in the range of pH 2 to 6, more preferably pH 2.5 to 5 in terms of the effect of improving unpleasant odor. For pH adjustment, an edible acid can be used as a pH adjuster. Examples of pH adjusting agents include citric acid, malic acid, tartaric acid, fumaric acid, lactic acid, succinic acid, ascorbic acid, acetic acid and other organic acids and salts thereof, hydrochloric acid and phosphoric acid and other inorganic acids and salts thereof, and the like. It is done. These pH adjusters can be used alone or in combination.

また、本発明の飲料には、ビタミンB2類以外のビタミン及びその塩類、メチオニン以外のアミノ酸およびその塩類、その他の生薬類、甘味剤、保存剤、矯味剤、着色剤など内服液剤一般に使用される成分を配合することができる。   The beverages of the present invention are generally used for oral liquids such as vitamins other than vitamin B2 and salts thereof, amino acids other than methionine and salts thereof, other herbal medicines, sweeteners, preservatives, corrigents, and coloring agents. Ingredients can be blended.

本発明にかかわる飲料組成物は、常法により調製でき、その方法は特に制限はされないが、通常、各成分を規定量以下の精製水にて混合し、規定量に容量調整し、必要に応じて濾過、滅菌処理をすることにより得られる。なお、脂溶性ビタミンを含むときは、通常用いられる界面活性剤又は可溶化剤により乳化又は可溶化してもよく、また分散剤を用いて懸濁させても良い。   The beverage composition according to the present invention can be prepared by a conventional method, and the method is not particularly limited. Usually, each component is mixed with purified water of a specified amount or less, the volume is adjusted to a specified amount, and if necessary. Obtained by filtration and sterilization. In addition, when fat-soluble vitamins are included, they may be emulsified or solubilized with commonly used surfactants or solubilizers, and may be suspended using a dispersant.

本発明の内服液剤は、例えば健康飲料、栄養補給飲料などの各種飲料、ドリンク剤、シロップ剤などの医薬品や医薬部外品の内服液剤に適用できる。   The internal liquid preparation of the present invention can be applied to various drinks such as health drinks and nutritional supplement drinks, pharmaceuticals such as drinks and syrups, and internal liquid preparations for quasi drugs.

本発明によって、メチオニンとビタミンB2類を同時配合すると経時的に増加する不快臭を抑制することがわかった。   According to the present invention, it has been found that when methionine and vitamin B2 are blended simultaneously, an unpleasant odor that increases with time is suppressed.

以下に、実施例および試験例により本発明の効果を詳細に説明する。   The effects of the present invention will be described in detail below with reference to examples and test examples.

メチオニン30mg、リン酸リボフラビンナトリウム5mgおよび表1記載の各成分を配合し、リン酸でpH3.0に調製して全量を精製水で50mLに調節して液剤を得た(生薬の配合では沈殿が生じるため、沈殿防止のためにHCO60とPVP(界面活性剤)を配合した)。   30 mg of methionine, 5 mg of riboflavin sodium phosphate and each component shown in Table 1 were mixed, adjusted to pH 3.0 with phosphoric acid, and the total amount was adjusted to 50 mL with purified water. Therefore, HCO60 and PVP (surfactant) were added to prevent precipitation).

Figure 0005040060
Figure 0005040060

比較例1
メチオニン30mg、リン酸リボフラビンナトリウム5mgおよび赤色3号50mgの各成分を配合し、リン酸でpH3.0に調製して全量を精製水で50mLに調節して液剤を得た。
Comparative Example 1
30 mg of methionine, 5 mg of riboflavin sodium phosphate and 50 mg of red No. 3 were mixed, adjusted to pH 3.0 with phosphoric acid, and the total amount was adjusted to 50 mL with purified water to obtain a solution.

比較例2
メチオニン30mg、リン酸リボフラビンナトリウム5mgおよびカルミン色素1.8mgを配合し、リン酸でpH3.0に調製して全量を精製水で50mLに調節して液剤を得た
Comparative Example 2
30 mg of methionine, 5 mg of riboflavin sodium phosphate and 1.8 mg of carmine dye were added, adjusted to pH 3.0 with phosphoric acid, and the total amount was adjusted to 50 mL with purified water to obtain a liquid preparation

試験例1
実施例1〜5の液剤、比較例1、2について、不快臭の程度を4人のパネラーによる官能試験により評価した。評価は臭いが、1:非常に弱い、2:比較的弱い、3:やや弱い、4:どちらでもない、5:やや強い、6:比較的強い、7:非常に強い、の7段階で評価し、各パネラーの平均値で評価した結果を図1に示した。
Test example 1
About the liquid agent of Examples 1-5, and Comparative Examples 1 and 2, the degree of unpleasant odor was evaluated by the sensory test by four panelists. Evaluation is odor, but 1: 7 very weak, 2: relatively weak, 3: slightly weak, 4: neither, 5: slightly strong, 6: relatively strong, 7: very strong And the result evaluated by the average value of each paneler was shown in FIG.

図から明らかなように本願発明の組成物は有意に臭いを抑制した。   As is clear from the figure, the composition of the present invention significantly suppressed odor.

試験例2
50mLあたりメチオニン30mg、リン酸リボフラビンナトリウム5mg配合し、リン酸でpH3.0に調製したものをコントロールとし、実施例6〜8の処方について匂いの評価を4人のパネラーによる官能試験(ビジュアルアナログスケール法)によって評価した。結果はコントロールを100としたときの臭いの強さで図2に示した。
Test example 2
50 mL of methionine 30 mg and riboflavin sodium phosphate 5 mg were mixed and adjusted to pH 3.0 with phosphoric acid as a control, and the odor evaluation of the formulations of Examples 6-8 was sensory test by 4 panelists (visual analog scale) Method). The results are shown in FIG. 2 in terms of odor intensity when the control is 100.

図から明らかなように本願発明の組成物は有意に臭いを抑制した。   As is clear from the figure, the composition of the present invention significantly suppressed odor.

試験例3
実施例10〜22で製造した液剤について匂いの評価を3人のパネラーによる官能試験(ビジュアルアナログスケール法)によって評価した。
Test example 3
The odor of the liquid preparations produced in Examples 10 to 22 was evaluated by a sensory test (visual analog scale method) using three panelists.

50mLあたりメチオニン30mg、リン酸リボフラビンナトリウム5mg配合し、リン酸でpH3.0に調製したものをコントロール(比較例3)とし、コントロールの値を基準としたときの臭いの抑制率を図3に示した。   Mixing 30 mg of methionine and 5 mg of riboflavin sodium phosphate per 50 mL and adjusting the pH to 3.0 with phosphoric acid was used as a control (Comparative Example 3), and the odor suppression rate based on the control value is shown in FIG. It was.

図から明らかなように本願発明の組成物は有意に臭いを抑制した。   As is clear from the figure, the composition of the present invention significantly suppressed odor.

試験例4
試験例1により有効性が認められた黄色5号について、その濃度を変更して匂いの評価を5人のパネラーにより、試験例1と同様に匂いの評価を行った。
Test example 4
About yellow No. 5 whose effectiveness was confirmed in Test Example 1, the concentration was changed and the odor was evaluated by five panelists in the same manner as in Test Example 1.

黄色5号を0.01%〜0.1%まで動かした処方の結果を図4に示した。   The result of the formulation in which Yellow No. 5 was moved from 0.01% to 0.1% is shown in FIG.

本発明によりメチオニンとビタミンB2を同時に配合しても不快臭がしない内服液剤を得ることができたので医薬品、食品、健康飲料、特定保健用食品などに使用可能である。   According to the present invention, an internal liquid preparation that does not cause an unpleasant odor even when methionine and vitamin B2 are blended simultaneously can be obtained, so that it can be used for pharmaceuticals, foods, health drinks, foods for specified health use, and the like.

各実施例および比較例の匂いを判定した結果であり、縦軸に点数、横軸に試料名を示した。It is the result of determining the odor of each example and comparative example, and the vertical axis shows the score and the horizontal axis shows the sample name. 各実施例の匂いを判定した結果であり、縦軸にコントロールを100とした際の匂い、横軸に試料名を示した。It is the result of determining the odor of each Example, the odor when the control is 100 on the vertical axis, and the sample name on the horizontal axis. 各実施例および比較例の匂いを判定した結果であり、縦軸に試料名、横軸に比較例4を0とした場合の匂いの強さを示した。It is the result of determining the odor of each Example and Comparative Example, and the vertical axis indicates the sample name, and the horizontal axis indicates the odor intensity when Comparative Example 4 is 0. 各試料の匂いを判定した結果であり、縦軸に点数、横軸に試料名を示した。It is the result of determining the odor of each sample, and the vertical axis shows the score and the horizontal axis shows the sample name.

Claims (1)

以下(1)〜(3)を含む内服液剤。
(1)メチオニン、
(2)リボフラビン、リン酸リボフラビン、酪酸リボフラビンまたはそれらの塩、
(3)液剤全体に対して0.01〜0.1W/V%の黄色5号、黄色4号、赤色2号、赤色102号および青色号から選ばれる1種または2種以上の着色料、並びに液剤全体に対して原生薬換算で0.005〜2W/V%のエゾウコギ、オウセイ、クコシ、トシシ、ビャクジュツから選ばれる生薬、から選ばれる1種または2種以上。
The internal use liquid agent containing following (1)-(3).
(1) methionine,
(2) riboflavin, riboflavin phosphate, riboflavin butyrate or a salt thereof,
(3) One or two or more colorants selected from Yellow No. 5, Yellow No. 4, Red No. 2, Red No. 102 and Blue No. 1 and 0.01 to 0.1 W / V% of the whole liquid agent, and the liquid agent One or more selected from herbal medicines selected from Ezoukogi, Ousei, Kokushi, Toshishi, and Bikkujutsu in terms of crude drug as a whole .
JP2004300219A 2004-10-14 2004-10-14 Methionine combination oral solution Expired - Fee Related JP5040060B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004300219A JP5040060B2 (en) 2004-10-14 2004-10-14 Methionine combination oral solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004300219A JP5040060B2 (en) 2004-10-14 2004-10-14 Methionine combination oral solution

Publications (2)

Publication Number Publication Date
JP2006111566A JP2006111566A (en) 2006-04-27
JP5040060B2 true JP5040060B2 (en) 2012-10-03

Family

ID=36380379

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004300219A Expired - Fee Related JP5040060B2 (en) 2004-10-14 2004-10-14 Methionine combination oral solution

Country Status (1)

Country Link
JP (1) JP5040060B2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128978B2 (en) 2005-06-10 2012-03-06 Calpis Co., Ltd. Method for preventing off-flavor in beverage composition
WO2011051742A1 (en) * 2009-10-28 2011-05-05 Modutech S.A. Preparation comprising amino acids and plants and its activity in the alcohol detoxification
JP2011102275A (en) * 2009-11-11 2011-05-26 Shiseido Co Ltd Tie2-activating agent, agent for maturing, normalizing or stabilizing blood vessel, lymphatic vessel-stabilizing agent, and wrinkle-preventing/ameliorating agent and dropsy-ameliorating/preventing agent
JP6008116B2 (en) * 2011-12-14 2016-10-19 大正製薬株式会社 Oral solution
MX2015007091A (en) * 2012-12-05 2015-09-25 Taisho Pharmaceutical Co Ltd Orally administered liquid formulation.
JP6475474B2 (en) * 2013-11-07 2019-02-27 興和株式会社 Beverage
JP6798314B2 (en) * 2014-11-27 2020-12-09 大正製薬株式会社 Aqueous liquid beverage
CN104840548A (en) * 2015-04-17 2015-08-19 杨定海 Apple polyphenol extraction method
CN104829665B (en) * 2015-04-20 2017-11-14 西安天一生物技术股份有限公司 A kind of method by protecting extraction rutin in advance
KR102279633B1 (en) * 2019-08-21 2021-07-21 주식회사 오스테온 Composition for removing aldehyde-based odor and active oxygen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01243975A (en) * 1988-03-23 1989-09-28 Taiyo Kagaku Co Ltd Preservation of food
JPH10287551A (en) * 1997-04-11 1998-10-27 Taisho Pharmaceut Co Ltd Liquid agent for internal use improved in unpleasant flavor of amino acid
JPH11124328A (en) * 1997-10-21 1999-05-11 Taisho Pharmaceut Co Ltd Internal liquid agent compounded with amino acid
JP3908872B2 (en) * 1999-02-16 2007-04-25 ハウスウェルネスフーズ株式会社 Clear royal jelly emulsion composition and method for producing the same
JP2000319177A (en) * 1999-05-14 2000-11-21 Taisho Pharmaceut Co Ltd Stress alleviating agent
JP2001010955A (en) * 1999-06-24 2001-01-16 Taisho Pharmaceut Co Ltd Internal administration solution composition
JP4780429B2 (en) * 2000-04-07 2011-09-28 大正製薬株式会社 Minoxidil-containing preparation
JP2002291406A (en) * 2001-04-03 2002-10-08 Ogawa & Co Ltd Agent for suppressing production of odor component due to deterioration of milk or milk product and method for suppressing production of odor component due to the same deterioration
JP4337308B2 (en) * 2001-06-22 2009-09-30 大正製薬株式会社 Liquid composition
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
EP1547587A4 (en) * 2002-08-22 2009-04-08 Ono Pharmaceutical Co Agent for reducing side effects of diclofenac
JP4749660B2 (en) * 2002-10-16 2011-08-17 武田薬品工業株式会社 Stable solid formulation
WO2005112667A1 (en) * 2004-05-20 2005-12-01 Takashi Omori Health food

Also Published As

Publication number Publication date
JP2006111566A (en) 2006-04-27

Similar Documents

Publication Publication Date Title
JP5259149B2 (en) Polyphenol-containing composition and method for suppressing astringency or astringency
RU2504221C2 (en) Astringency reduction in compositions containing phenolic compounds
JP4257934B2 (en) Method for stabilizing vitamin K2
JP5040060B2 (en) Methionine combination oral solution
JP2008271839A (en) Water-soluble flavonoid composition, preparing method therefor and foodstuff etc. containing water-soluble flavonoid composition
JP6742710B2 (en) Beverage and/or astringency masked polyphenol-containing food and drink
JP2013212122A (en) Beverage composition and method of reducing degradation of monatin
JPWO2007125883A1 (en) Sleep improvement composition
JP4138511B2 (en) Anti-fading agent for dyes
JP4168811B2 (en) Beverage composition
JP6880757B2 (en) Oral liquid composition
JP4100224B2 (en) Beverage composition
JP2001316259A (en) Preparation of polyphenols
JP2006257010A (en) WATER-SOLUBLE COMPOSITION OF alpha-LIPOIC ACID, BEVERAGE OR FOOD AND COSMETIC EACH CONTAINING THE SAME COMPOSITION AND METHOD FOR PRODUCING THE SAME COMPOSITION
JP6679845B2 (en) Beverage
WO2013141267A1 (en) Polyphenol stabilizer, and composition and processed goods containing said stabilizer
JP2021016380A (en) Agent for helping make emulsion particles finer, for suppressing formation of coarse particles or improving emulsification stability
JP4111039B2 (en) Beverage composition
JP4311251B2 (en) Beverage composition
JP2004250390A (en) Iron compound-mixed oral liquid
JP2002128703A (en) Crude drug blended solubilized liquid composition
JP2001309764A (en) Composition of polyphenol compounds
JP2002080347A (en) Oral liquid medicine formulated with iron compound
JP5125146B2 (en) Oral solution
JP7249764B2 (en) LIQUID COMPOSITION CONTAINING POLYPHENOLS AND SUPPRESSED PRECIPITATION

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071003

RD07 Notification of extinguishment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7427

Effective date: 20090605

RD07 Notification of extinguishment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7427

Effective date: 20090624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110421

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120117

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120413

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120612

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120625

R150 Certificate of patent or registration of utility model

Ref document number: 5040060

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150720

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150720

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees